http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5091194-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c7a61a81e368cb08e8c851eee064ba4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
filingDate 1988-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84376889d12dc7ac38fd7b2f0838245b
publicationDate 1992-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5091194-A
titleOfInvention Cosmetic compositions comprising a native mineral substance for the treatment of phlebectasiae and process for preparing same
abstract The invention relates to cosmetic compositions for the treatment of phlebectasiae, particularly haemorrhoids and phlebectasiae mainly occurring on the lower limbs optionally accompanied with phlebitis, as well as for relieving the phlebalgia thereby induced, with comprises potassium aluminum sulfate and/or one or more hydrates thereof in admixture with one or more cosemtically acceptable carriers, auxiliary and optionally odorizing materials commonly used in the preparation of cosmetics. n The compositions according to the invention preferably contain potassium aluminum sulfate dodecahydrate in an amount of 10 to 90% by weight, most preferably 40 to 70% by weight and are preferably formulated to ointments, creams, lotions or pastes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6267962-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5206016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9727837-A1
priorityDate 1987-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4613498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3180827-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426087443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453308282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57069340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449118059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128515668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127716640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9947828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454104047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409406165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128732144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449166076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135887601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555779

Total number of triples: 50.